DARPP-32 binds to tra2-beta1 and influences alternative splicing

  • Natalya Benderska
  • , Kristina Becker
  • , Jean Antoine Girault
  • , Cord Michael Becker
  • , Athena Andreadis
  • , Stefan Stamm

Producción científica: Articlerevisión exhaustiva

16 Citas (Scopus)

Resumen

The majority of human genes undergo alternative splicing, which is frequently altered in response to physiological stimuli. DARPP-32 (dopamine and cAMP regulated phosphoprotein, 32 kDa) is a component of PKA-dependent signaling pathways. Here we show that DARPP-32 binds directly to the splicing factor tra2- beta1 (transformer 2). DARPP-32 changes the usage of tra2-beta1 dependent alternative exons in a concentration-dependent manner, suggesting that the DARPP-32:tra2-beta1 interaction is a molecular link between signaling pathways and pre-mRNA processing.

Idioma originalEnglish
Páginas (desde-hasta)448-453
Número de páginas6
PublicaciónBiochimica et Biophysica Acta - Gene Regulatory Mechanisms
Volumen1799
N.º5-6
DOI
EstadoPublished - 2010

Financiación

FinanciadoresNúmero del financiador
Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentR21HD056195

    ASJC Scopus subject areas

    • Biophysics
    • Structural Biology
    • Biochemistry
    • Molecular Biology
    • Genetics

    Huella

    Profundice en los temas de investigación de 'DARPP-32 binds to tra2-beta1 and influences alternative splicing'. En conjunto forman una huella única.

    Citar esto